Kelly C. G. de Moura

Statistics

Publications

Citations

341

H-Index

Active since

1997

Affiliations

Universidade Federal do Rio de Janeiro(Current)

Universidade Federal do Rio Grande

Fundação Oswaldo Cruz

Universidade de São Paulo

Kelly C. G. de Moura is an author at Universidade Federal do Rio de Janeiro specializing in pharmacology, medicinal chemistry, and tuberculosis drug resistance.

Publications per year

1997–2020

Publications

Studies on the trypanocidal activity of semi-synthetic pyran[b-4,3]naphtho[1,2-d]imidazoles from β-lapachone

Kelly C. G. de Moura, Kelly Salomão, Rubem F.S. Menna-Barreto et al. · European Journal of Medicinal Chemistry · 2004 · 71 citations

Natural Sciences, Chemistry, Medicinal Chemistry +10

1,3-Azoles from ortho-naphthoquinones: Synthesis of aryl substituted imidazoles and oxazoles and their potent activity against Mycobacterium tuberculosis

Kelly C. G. de Moura, Paula F. Carneiro, Maria do Carmo F. R. Pinto et al. · Bioorganic & Medicinal Chemistry · 2012 · 50 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

Naphthoquinone Derivatives as Scaffold to Develop New Drugs for Tuberculosis Treatment

Priscila Cristina Bartolomeu Halicki, Laís A. Ferreira, Kelly C. G. de Moura et al. · Frontiers in Microbiology · 2018 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Activity of β-lapachone derivatives against rifampicin-susceptible and -resistant strains of Mycobacterium tuberculosis

Tatiane S. Coelho, Raphael S. F. Silva, António Pinto et al. · Tuberculosis · 2010 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Quinonoid and phenazine compounds: Synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis

Paula F. Carneiro, Maria do Carmo F. R. Pinto, Tatiane S. Coelho et al. · European Journal of Medicinal Chemistry · 2011 · 31 citations

Medicine, Medicinal Chemistry, Pharmacology +14

1–5 of 13